Exposure to artemether-lumefantrine (Coartem®) in first trimester pregnancy in an observational study in Zambia

BACKGROUND: In general, safety data following exposure to drugs in the first trimester of pregnancy are scarce. More specifically, data on the safety of artemisinin-based combination therapy (ACT) in pregnancy still remain limited. Therefore, pregnant women from Choma, Zambia, who were exposed to ar...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Malar J
Hlavní autoři: Manyando, Christine, Njunju, Eric M, Virtanen, Mailis, Hamed, Kamal, Gomes, Melba, Van geertruyden, Jean-Pierre
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336694/
https://ncbi.nlm.nih.gov/pubmed/25877884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0578-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky